Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model.
作者信息
Ludwig Julia, Scally Stephen W, Costa Giulia, Hoffmann Sandro, Murugan Rajagopal, Lossin Jana, Prieto Katherine, Obraztsova Anna, Lobeto Nina, Franke-Fayard Blandine, Janse Chris J, Lebas Celia, Collin Nicolas, Binter Spela, Kellam Paul, Levashina Elena A, Wardemann Hedda, Julien Jean-Philippe
机构信息
B Cell Immunology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Program in Molecular Medicine, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.
出版信息
NPJ Vaccines. 2023 Jun 5;8(1):86. doi: 10.1038/s41541-023-00687-x.
Abstract
摘要
相似文献
1
Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model.作者更正：基于糖基化纳米颗粒的PfCSP疫苗在小鼠疟疾模型中可产生持久的抗体反应和无菌保护。
NPJ Vaccines. 2023 Jun 5;8(1):86. doi: 10.1038/s41541-023-00687-x.
2
Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model.基于糖基化纳米颗粒的恶性疟原虫环子孢子蛋白疫苗在小鼠疟疾模型中可产生持久的抗体反应和无菌保护。
NPJ Vaccines. 2023 Apr 7;8(1):52. doi: 10.1038/s41541-023-00653-7.
3
Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine.纳米颗粒疫苗诱导的针对恶性疟原虫环子孢子蛋白的保护性抗体和CD8+ T细胞反应。
PLoS One. 2012;7(10):e48304. doi: 10.1371/journal.pone.0048304. Epub 2012 Oct 29.
4
Liver-Directed AAV8 Booster Vaccine Expressing Antigen Following Adenovirus Vaccine Priming Elicits Sterile Protection in a Murine Model.腺病毒疫苗初免后靶向肝脏的 AAV8 增强型疫苗表达抗原可在小鼠模型中诱导无菌保护。
Front Immunol. 2021 Jun 23;12:612910. doi: 10.3389/fimmu.2021.612910. eCollection 2021.
5
Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine.由恶性疟原虫环子孢子蛋白为基础的自组装蛋白纳米颗粒疫苗诱导的保护性免疫应答的机制。
Malar J. 2013 Apr 22;12:136. doi: 10.1186/1475-2875-12-136.
6
Down-selecting circumsporozoite protein-based malaria vaccine: A comparison of malaria sporozoite challenge model.基于环子孢子蛋白的疟疾疫苗的选择：疟疾孢子虫挑战模型的比较。
Parasite Immunol. 2019 May;41(5):e12624. doi: 10.1111/pim.12624.
7
Increased levels of anti-PfCSP antibodies in post-pubertal females versus males immunized with PfSPZ Vaccine does not translate into increased protective efficacy.与 PfSPZ 疫苗免疫的青春期后男性相比，青春期后女性的抗 PfCSP 抗体水平升高，但并未转化为更高的保护效力。
Front Immunol. 2022 Oct 25;13:1006716. doi: 10.3389/fimmu.2022.1006716. eCollection 2022.
8
Needle-free, spirulina-produced Plasmodium falciparum circumsporozoite vaccination provides sterile protection against pre-erythrocytic malaria in mice.无针、螺旋藻产生的恶性疟原虫环子孢子蛋白疫苗可在小鼠中提供针对红细胞前期疟疾的无菌保护。
NPJ Vaccines. 2022 Oct 4;7(1):113. doi: 10.1038/s41541-022-00534-5.
9
A potent malaria vaccine based on adenovirus with dual modifications at Hexon and pVII.基于腺病毒的改良 Hexon 和 pVII 的强效疟疾疫苗。
Vaccine. 2017 Dec 15;35(50):6990-7000. doi: 10.1016/j.vaccine.2017.10.066. Epub 2017 Oct 28.
10
Editorial: The First Monoclonal Antibody Vaccine to Prevent Malaria Heralds a New Era of Malaria Vaccines to the Plasmodium falciparum Circumsporozoite Protein (PfCSP).社论：首个预防疟疾的单克隆抗体疫苗预示着针对恶性疟原虫环子孢子蛋白（PfCSP）的疟疾疫苗新时代的到来。
Med Sci Monit. 2021 Sep 13;27:e934676. doi: 10.12659/MSM.934676.
引用本文的文献
1
PfCSP-ferritin nanoparticle malaria vaccine antigen formulated with aluminum-salt and CpG 1018® adjuvants: Preformulation characterization, antigen-adjuvant interactions, and mouse immunogenicity studies.用铝盐和CpG 1018®佐剂配制的PfCSP-铁蛋白纳米颗粒疟疾疫苗抗原：制剂前表征、抗原-佐剂相互作用及小鼠免疫原性研究
Hum Vaccin Immunother. 2025 Dec;21(1):2460749. doi: 10.1080/21645515.2025.2460749. Epub 2025 Feb 4.
Zotero 插件